Stereotactic abative body radiotherapy (SABR) for oligometastatic prostate cancer: a prospective clinical trial S Siva, M Bressel, DG Murphy, M Shaw, S Chander, J Violet, KH Tai, ... European urology 74 (4), 455-462, 2018 | 317 | 2018 |
The additive diagnostic value of prostate-specific membrane antigen positron emission tomography computed tomography to multiparametric magnetic resonance imaging triage in the … L Emmett, J Buteau, N Papa, D Moon, J Thompson, MJ Roberts, K Rasiah, ... European urology 80 (6), 682-689, 2021 | 315 | 2021 |
Laparoscopic pyeloplasty: evolution of a new gold standard DA Moon, MA El-Shazly, CM Chang, TR Gianduzzo, CG Eden urology 67 (5), 932-936, 2006 | 297 | 2006 |
Sepsis and ‘superbugs’: should we favour the transperineal over the transrectal approach for prostate biopsy? JP Grummet, M Weerakoon, S Huang, N Lawrentschuk, M Frydenberg, ... BJU international 114 (3), 384-388, 2014 | 282 | 2014 |
Survival and complications following surgery and radiation for localized prostate cancer: an international collaborative review CJD Wallis, A Glaser, JC Hu, H Huland, N Lawrentschuk, D Moon, ... European urology 73 (1), 11-20, 2018 | 130 | 2018 |
Patient-derived models of abiraterone-and enzalutamide-resistant prostate cancer reveal sensitivity to ribosome-directed therapy MG Lawrence, D Obinata, S Sandhu, LA Selth, SQ Wong, LH Porter, ... European urology 74 (5), 562-572, 2018 | 107 | 2018 |
PADUA and RENAL nephrometry scores correlate with perioperative outcomes of robot‐assisted partial nephrectomy: analysis of the Vattikuti Global Quality Initiative in Robotic … R Schiavina, G Novara, M Borghesi, V Ficarra, R Ahlawat, DA Moon, ... BJU international 119 (3), 456-463, 2017 | 107 | 2017 |
Stereotactic radiotherapy and short-course pembrolizumab for oligometastatic renal cell carcinoma—the RAPPORT trial S Siva, M Bressel, ST Wood, MG Shaw, S Loi, SK Sandhu, B Tran, ... European urology 81 (4), 364-372, 2022 | 106 | 2022 |
The PRIMARY score: using intraprostatic 68Ga-PSMA PET/CT patterns to optimize prostate cancer diagnosis L Emmett, N Papa, J Buteau, B Ho, V Liu, M Roberts, J Thompson, ... Journal of Nuclear Medicine 63 (11), 1644-1650, 2022 | 103 | 2022 |
The impact of prostate size in laparoscopic radical prostatectomy CM Chang, D Moon, TR Gianduzzo, CG Eden European urology 48 (2), 285-290, 2005 | 97 | 2005 |
Zero hospital admissions for infection after 577 transperineal prostate biopsies using single-dose cephazolin prophylaxis L Pepdjonovic, GH Tan, S Huang, S Mann, M Frydenberg, D Moon, ... World journal of urology 35, 1199-1203, 2017 | 91 | 2017 |
Laparoscopic pyeloplasty: status and review of literature MA El-Shazly, DA Moon, CG Eden Journal of endourology 21 (7), 673-678, 2007 | 78 | 2007 |
Patterns‐of‐care and health economic analysis of robot‐assisted radical prostatectomy in the Australian public health system M Basto, N Sathianathen, L Te Marvelde, S Ryan, J Goad, ... BJU international 117 (6), 930-939, 2016 | 70 | 2016 |
Fractionated stereotactic body radiotherapy for up to five prostate cancer oligometastases: Interim outcomes of a prospective clinical trial P Bowden, AW See, M Frydenberg, H Haxhimolla, AJ Costello, D Moon, ... International Journal of Cancer 146 (1), 161-168, 2020 | 68 | 2020 |
Outcomes of artificial urinary sphincter implantation in the irradiated patient NJ Sathianathen, SM McGuigan, DA Moon BJU international 113 (4), 636-641, 2014 | 68 | 2014 |
Retroperitoneal vs transperitoneal robot-assisted partial nephrectomy: comparison in a multi-institutional setting S Arora, G Heulitt, M Menon, W Jeong, RK Ahlawat, U Capitanio, ... Urology 120, 131-137, 2018 | 67 | 2018 |
Mini‐flank supra‐11th rib incision for open partial or radical nephrectomy CJ DiBLASIO, ME Snyder, P Russo BJU international 97 (1), 149-156, 2006 | 66 | 2006 |
Transperineal biopsy prostate cancer detection in first biopsy and repeat biopsy after negative transrectal ultrasound‐guided biopsy: the Victorian transperineal biopsy … WL Ong, M Weerakoon, S Huang, E Paul, N Lawrentschuk, M Frydenberg, ... BJU international 116 (4), 568-576, 2015 | 65 | 2015 |
The MURAL collection of prostate cancer patient-derived xenografts enables discovery through preclinical models of uro-oncology GP Risbridger, AK Clark, LH Porter, R Toivanen, A Bakshi, NL Lister, ... Nature communications 12 (1), 5049, 2021 | 57 | 2021 |
Extraprostatic extension into periprostatic fat is a more important determinant of prostate cancer recurrence than an invasive phenotype J Kapoor, B Namdarian, J Pedersen, C Hovens, D Moon, J Peters, ... The Journal of urology 190 (6), 2061-2067, 2013 | 56 | 2013 |